Zai Lab Ltd (ZLAB)

↓ Download CSV

CIK 0001704292 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated E9
  • Fiscal year ends Dec 31

In fiscal 2025, Zai Lab Ltd reported revenue of $457.18M, up 15.0% from the prior year. The company ran a net loss, with a net margin of -38.4%. It held $1.17B in total assets against $456.88M in total liabilities.

Key ratios (FY2025)

-50.2%
Operating margin
-38.4%
Net margin
-24.5%
Return on equity
+15.0%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$457.18M$397.61M$266.72M$212.67M$144.10M$48.96M$12.98M$129.0K
Cost of Revenue$190.52M$147.12M$95.82M$74.02M
Gross Profit$85.9K
Operating Income-$229.43M-$282.12M-$366.57M-$404.36M-$700.06M-$301.80M-$203.20M-$141.77M-$51.39M-$38.53M
Net Income-$175.54M-$257.10M-$334.62M-$443.29M-$704.47M-$268.90M-$195.07M-$139.07M-$50.38M-$37.51M
EPS (Diluted)$-0.16$-0.26$-0.35$-0.46$-0.76$-0.35
Total Assets$1.17B$1.19B$1.04B$1.22B$1.61B$1.30B$355.15M$301.99M$249.63M$88.91M
Total Liabilities$456.88M$344.86M$240.18M$174.54M$230.00M$128.29M$60.49M$50.91M$14.46M$5.95M
Shareholders' Equity$715.50M$840.90M$796.12M$1.05B$1.38B$1.17B$294.66M$251.08M$235.17M-$51.55M
Cash & Equivalents$679.57M$449.67M$790.15M$1.01B$964.10M$442.12M$75.93M$62.95M$229.66M$83.95M
Operating Cash Flow-$150.79M-$214.87M-$198.18M-$367.64M-$549.23M-$216.06M-$191.01M-$97.54M-$32.37M-$32.16M
Capital Expenditures$8.10M$5.66M$7.21M$24.59M$18.30M$10.13M$6.04M$10.02M$9.10M$2.22M
Shares Outstanding1.11B1.08B972.24M960.22M954.98M87.81M68.24M58.01M49.91M9.66M